Cysteine Reactivity Distinguishes Redox Sensing by the Heat-Inducible and Constitutive Forms of Heat Shock Protein 70  by Miyata, Yoshinari et al.
Chemistry & Biology
ArticleCysteine Reactivity Distinguishes Redox Sensing
by the Heat-Inducible and Constitutive Forms
of Heat Shock Protein 70
Yoshinari Miyata,1,3 Jennifer N. Rauch,1,3 Umesh K. Jinwal,2 Andrea D. Thompson,1 Sharan Srinivasan,1 Chad A. Dickey,2
and Jason E. Gestwicki1,*
1Department of Pathology, Department of Biological Chemistry, and the Life Sciences Institute, University of Michigan, Ann Arbor,
MI 48109-2216, USA
2Department of Molecular Medicine, University of South Florida, 4001 E. Fletcher Avenue, MDC 36, Tampa, FL 33613, USA
3These authors contributed equally to this work
*Correspondence: gestwick@umich.edu
http://dx.doi.org/10.1016/j.chembiol.2012.07.026SUMMARY
The heat shock protein 70 (Hsp70) family ofmolecular
chaperones has important functions in maintain-
ing proteostasis under stress conditions. Several
Hsp70 isoforms, especially Hsp72 (HSPA1A), are
dramatically upregulated in response to stress;
however, it is unclear whether these family members
have biochemical properties that are specifically
adapted to these scenarios. The redox-active com-
pound, methylene blue (MB), has been shown to
inhibit the ATPase activity of Hsp72 in vitro, and it
promotes degradation of the Hsp72 substrate, tau,
in cellular and animal models. Here, we report that
MB irreversibly inactivates Hsp72 but not the nearly
identical, constitutively expressed isoform, heat
shock cognate 70 (Hsc70; HSPA8). Mass spectrom-
etry results show that MB oxidizes Cys306, which is
not conserved in Hsc70. Molecular models sug-
gested that oxidation of Cys306 exposes Cys267 to
modification and that both events contribute to loss
of ATP binding in response to MB. Consistent with
this model, mutating Cys267 and Cys306 to serine
madeHsp72 largely resistant toMB in vitro, and over-
expression of the C306S mutant blocked MB-
mediated loss of tau in a cellular model. Furthermore,
mutating Cys267 and Cys306 to the pseudo-oxida-
tion mimic, aspartic acid, mirrored MB treatment:
the C267D and C306D mutants had reduced
ATPase activity in vitro, and overexpression of the
C267/306D double mutant significantly reduced tau
levels in cells. Together, these results suggest that
redox sensing by specific cysteine residues in
Hsp72, but not Hsc70, may be an important compo-
nent of the chaperone response to oxidative stress.
INTRODUCTION
Reactive oxygen species (ROS), such as free radicals and perox-
ides, are produced as the result of normal metabolic andChemistry & Biology 19, 1391–139signaling processes (Forman et al., 2010; Giles et al., 2003;
Paulsen and Carroll, 2010). However, an abundance of ROS is
also implicated in oxidative damage to lipids, nucleic acids,
and proteins, contributing to pathology in a number of diseases
(Lin and Beal, 2006; Patten et al., 2010; Waris and Ahsan, 2006).
Thus, to control the accumulation of ROS, organisms are equip-
ped with several scavengers, such as glutathione and ascorbate
(Apel and Hirt, 2004), and redox-sensitive transcription factors,
including HIF1a (Majmundar et al., 2010), NF-kB (Morgan and
Liu, 2011), and HSF1 (Zhang et al., 2011), that coordinate cellular
adaptation to ROS. Another important cellular response is to
protect the proteome from acute denaturation and aggregation,
which could cause proteotoxicity. This type of ROS protection is
often provided by amolecular chaperone that contains a reactive
redox sensor (e.g., cysteine residue) linked to a system for pro-
tecting other proteins from oxidative unfolding. For example,
the prokaryotic heat shock protein 33 (Hsp33) contains cysteine
residues that are selectively oxidized in response to redox
stress, which induces a conformation with high chaperone
activity (Ilbert et al., 2007).
The heat shock protein 70 (Hsp70) family is a series of highly
conserved molecular chaperones that are well known for their
activity in maintaining global proteostasis. Hsp70s are involved
in most steps in the life of a protein, including the folding of
nascent polypeptides, protein trafficking, and degradation (Hartl
et al., 2011). Members of the Hsp70 family specifically interact
with unfolded substrates through a C-terminal, substrate-
binding domain (SBD). In addition, Hsp70s also have a con-
served N-terminal nucleotide-binding domain (NBD), which
binds and hydrolyzes ATP. These two domains are allosterically
coupled, such that ATP hydrolysis within the NBD causes
conformational changes in the SBD that enhance affinity for
unfolded substrates (Mayer et al., 2000). In turn, binding of
Hsp70s to unfolded proteins protects them against aggregation
and assists with their refolding. However, if this process fails,
Hsp70s are also involved in triage, shuttling misfolded proteins
to the proteasome for turnover (Mayer and Bukau, 2005).
Through these activities, Hsp70s have been linked to diseases
associated with aberrant protein quality control, such as cancer
and neurodegenerative disease (Evans et al., 2010; Patury et al.,
2009). In addition, like Hsp33, Hsp70s have been linked to redox
signaling based on its reactive cysteine residues (Liu et al.,
1996; Vignols et al., 2003).9, November 21, 2012 ª2012 Elsevier Ltd All rights reserved 1391
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Hsp72 Is a Redox Sensitive ChaperoneIn humans, the cytosol contains at least six Hsp70 isoforms,
including the constitutively expressed Hsc70 (HSPA8) and the
major stress-inducible isoform, Hsp72 (HSPA1A) (Hageman
et al., 2011). Hsp72 and Hsc70 have very high sequence
similarity (85% identical and 94% similar). However, the levels
of Hsp72 are typically low under normal conditions, and they
are only highly induced in response to stress, including redox
imbalance (Lindquist, 1986). Thus, Hsp72 belongs to a subfamily
of Hsp70s, including HSPA6, HSPA7, and HSPA4, which is char-
acterized by elevated expression in response to stress. One
important question is whether the different family members,
such as the stress-inducible forms, have any specialized
biochemical functions that might distinguish them from the
constitutive ones.
Previously, we identifiedmethylene blue (MB) as an inhibitor of
the ATPase activity of Hsp72 in a high throughput chemical
screen (Jinwal et al., 2009). This compound has been shown to
reduce the levels of some Hsp72 substrates, such as tau, poly-
glutamine fragments, and Akt, in cells (Congdon et al., 2012;
Jinwal et al., 2009; Koren et al., 2010; Wang et al., 2010). MB
also improves cognitive functions in mouse models of
Alzheimer’s disease (AD) (Congdon et al., 2012; O’Leary et al.,
2010), and it has been explored in Phase IIb clinical trials in AD
patients (Wischik et al., 2008). Although MB is a highly promis-
cuous compound, it has an enviable safety record and is used
clinically for multiple indications (Schirmer et al., 2011). For these
reasons, we decided to further explore the mechanism by which
it might inactivate Hsp70s. Specifically, we hypothesized that
MB might prevent ATP turnover in Hsp72 by oxidizing cysteine
residues (Liu et al., 1996; Oz et al., 2009), because MB has
been shown to oxidize sulfhydryls in other targets (Kelner and
Alexander, 1985). Here, we report that Hsp72 is indeed oxidized
by MB and that treatment with either MB or hydrogen peroxide
irreversibly inactivates ATP turnover in vitro. Based on modeling
studies andmutagenesis, this inhibition appears to be caused by
oxidation-induced conformation changes in the NBD that block
ATP binding. However, during the course of these studies, we
also made the unexpected observation that the constitutive
Hsp70 family member, Hsc70, is entirely resistant to irreversible
inhibition byMB.Mass spectrometry and point mutants revealed
that two reactive cysteines, C267S and C306S, are sufficient to
distinguish the special sensitivity of Hsp72 to MB in vitro and in
cells. Cys306 is highly conserved in the other stress-inducible
Hsp70 isoforms, but it is absent from constitutive forms, sup-
porting the idea that this residue is important in stress-related
redox signaling. Thus, these finding suggest a major difference
between closely related Hsp70 isoforms, which may be impor-
tant in redox signaling and protecting cells from oxidative stress.
Moreover, this work may provide insight into one mechanism by
which MB reduces tau accumulation in cells, animals, and AD
patients.
RESULTS
MB and H2O2 Irreversibly Inhibits Hsp72 but Not Hsc70
Because MB has been known to directly oxidize sulfhydryls
(Kelner and Alexander, 1985), we hypothesized that the inhibi-
tion of Hsp70’s ATPase activity by MB (Jinwal et al., 2009;
Miyata et al., 2011) may involve oxidation of cysteines. To1392 Chemistry & Biology 19, 1391–1399, November 21, 2012 ª2012test this idea, Hsp72 was treated with MB (200 mM) at 37C
for 1 hr and then dialyzed to remove any remaining compound.
The remaining ATPase activity in the MB-treated Hsp72 sample
was then measured using a malachite green assay (Chang
et al., 2008). Because Hsp72 is a weak ATPase, the stimulatory
cochaperone, DnaJ, was added to enhance nucleotide turnover
in these experiments. Using this approach, we found that MB-
treated Hsp72 had dramatically reduced ATPase activity (Fig-
ure 1A). Hsp72 was also inhibited by treatment with hydrogen
peroxide (100 mM) under similar conditions, suggesting that
the loss of activity may be due to oxidation (Figure 1A).
Cysteine residues in proteins can be progressively oxidized to
sulfenic, sulfinic and then sulfonic acids (Reddie and Carroll,
2008), but only sulfenic acids are readily reversible by gluta-
thione or dithiothreitol (DTT) (Poole et al., 2004). The ATPase
activity of MB-treated Hsp72 was only partially (80%) recov-
ered after exposure to DTT (1 mM) (Figure S1A available online),
suggesting that MB oxidizes the protein to a mixture of oxida-
tion states.
Initially as a control, the effects of MB on the ATPase activity of
Hsc70 were evaluated. Unexpectedly, we found that MB had no
effect on Hsc70 (Figure 1B). The chemical differences between
these two well-conserved (85% identical and 94% similar)
Hsp70 isoforms were then more closely examined. Sequence
alignments of the human proteins showed that Hsp72 has five
cysteine residues (three in theNBD and two in the SBD), whereas
Hsc70 has only four (two each in the NBD and SBD). Thus, one
difference between these isoforms is that Hsp72 has a unique
Cys306, which is an asparagine in Hsc70 (Figure 1C). The
sequences of a number of inducible or constitutive human
Hsp70 family members were then examined, revealing that
Cys306 is exclusively found in stress-inducible Hsp70s but not
in any of the constitutively expressed family members (Fig-
ure S2A). Moreover, C267 is conserved in four of five inducible
family members and only two of five constitutive forms (Fig-
ure S2A), suggesting that both of these residues may be impor-
tant. Together, these results suggest that MB might selectively
compromise ATPase by oxidizing at least one cysteine in
Hsp72 but not Hsc70.
MB Oxidizes Cys306 of Hsp72
To map which cysteines in Hsp72 were oxidized by MB, a well-
established mass spectrometry (MS) method using dimedone
(5,5-dimethyl-1,3-cyclohexanedione) was used. Briefly, dime-
done is known to react with oxidized cysteines to form stable
thioethers that are readily observed in the MS spectra as
a 138 Da shift in molecular mass (Figure 2A). Accordingly, MB-
treated Hsp72 was treated with dimedone, and unreacted thiols
were capped with carbamidomethyl groups. Subsequent trypsin
digestions and analysis by liquid chromatography-tandem mass
spectrometry (LC-MS/MS) revealed that the mass of the frag-
ment containing Cys306 in Hsp72 was oxidized (Figure 2B). No
other residues were modified, although it is important to note
that the fragment containing Cys267 was not detected (this is
likely because the nearby region is highly charged) (Figure 2C).
As expected from the ATPase experiments, Hsc70 treated with
MB was resistant to modification by dimedone (Figure 2C; Fig-
ure S2B). Thus, Hsp72 differs from Hsc70 in reactivity of its
cysteines at positions 306 and perhaps 267.Elsevier Ltd All rights reserved
Figure 1. The ATPase Activity of Hsp72, but Not Hsc70, Is Sensitive to Oxidation
(A) Purified Hsp72 (0.6 mM) was incubated with either MB, peroxide (H2O2), or a mock control and the remaining compound was removed by extensive dialysis.
The stimulation of ATPase activity by the model J cochaperone, DnaJ, was then measured. Results are the average of three experiments performed in triplicate.
Error bars, SEM.
(B) Human Hsc70 is resistant to oxidation. Experiments were performed as described for (A).
(C) The locations of cysteine residues (red) in Hsp72 are shown using the crystal structures of the NBD (Protein Data Bank [PDB] ID: 3JXU; shown in yellow) and
the SBD (PDB ID: 1DKX; shown in green). In the insets, identical residues are shown in yellow, conserved residues are shown in gray, and the positions of
cysteines are shown in red. Alignments were prepared in Vector NTI (Invitrogen). The chemical structure of MB is shown.
See Figure S2 for the expanded alignment.
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Hsp72 Is a Redox Sensitive ChaperoneHsp72 Cys to Ser Mutations Confer Resistance to MB
The MS studies suggested that MB-based oxidation of specific
cysteines might be responsible for the compound’s effects on
Hsp720s ATPase activity. To test this idea, Cys306, Cys267, or
both residues were mutated to serine by site-directed mutagen-
esis, and the resulting mutant proteins were purified. These
substitutions did not change the global structure (Figure S3) or
ATPase activity of the mutant chaperones (Figures 3A–3C).
However, the ATPase activities of C267S (Figure 3A) and
C306S (Figure 3B) were partially resistant to MB (50 mM), and
the double mutant (C267/306S) was completely resistant (Fig-
ure 3C). Thus, MB appeared to exert its inhibitory effect on
Hsp72 ATPase activity via oxidation of these cysteines, and
both residues appeared to be involved.
MB is known to reduce tau levels in cells through amechanism
dependent on Hsp72 (Jinwal et al., 2009). Thus, the overexpres-
sion of the C306S, C267S, and C267/306S mutants may
desensitize cells to MB. In fact, when HeLaC3 cells were stably
transfected with Hsp72 C306S, MB no longer reduced the levels
of phosphorylated (pS396/404) or total tau (Figure 3D). Together,
these results strongly suggest that MB acts on Hsp72 byChemistry & Biology 19, 1391–139oxidizing Cys267 and Cys306 and that this activity is important
in regulating the levels of tau.
C267D Mutation Causes a Conformational Change and
Disrupts Nucleotide Binding
To gain some insight into the structural basis of these observa-
tion, the NBD of Hsp72 containing a C267D mutation was
modeled using Robetta (Kim et al., 2004), with the structure of
human Hsp72 NBD in the ADP form (3JXU) as a starting point
(Wisniewska et al., 2010). An aspartic acid substitution was
used because it sterically and electronically mimics a sulfinic
acid (Permyakov et al., 2012), one of the possible oxidation
states sampled by MB-treated cysteine residues. A comparison
of the structures of the wild-type Hsp72 NBD and the C267D
Hsp72 NBD showed that they were globally very similar, with
an root-mean-square deviation (RMSD) of 1.55 A˚ and a template
modeling score of 0.94 (Figure 4A). However, several residues
that are specifically involved in nucleotide binding were pre-
dicted to be significantly shifted. For example, Gly339, which
makes a hydrogen bond interaction with the alpha phosphate
group of ADP, was shifted away from the nucleotide by 1.0 A˚,9, November 21, 2012 ª2012 Elsevier Ltd All rights reserved 1393
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Figure 2. Hsp72 Is Oxidized by MB at Specific Cysteine Residues
(A) Schematic of the specific reactions of iodoacetimide with free thiol and dimedone with sulfenic acid, producing a mass shift of 57 or 138 Da, respectively.
(B) Select region of the MS/MS spectra focused on the region including the C306 fragment (CSDLFR 306-311). This fragment is 797.39 Da in the mock-treated
control (indicating iodoacetamide capping) and 878.43 Da in the MB-treated (indicating dimedone conjugation).
(C) Summary of the MS findings, showing that MB only oxidized C306 in Hsp72. n.d. = not detected. n.a = residue not conserved.
See Figure S1 for the DTT reversibility.
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Hsp72 Is a Redox Sensitive Chaperonelikely preventing the formation of this important bond (Figure 4B).
Furthermore, Arg272, which interacts with the adenine ring by
pi-stacking, is significantly pulled away by regional rotations in
the backbone (Figure 4C). Collectively, these changes and
others (Table S1) resulted in side-chain displacements totaling
more than 25 A˚ in the nucleotide binding cleft. Very similar results
were seen with the C306D mutant, suggesting that these resi-
dues might both contribute to conformational rearrangements
(Figure S4A). It is interesting that oxidation of C306 is predicted
to swivel residue C267 into the solvent-exposed cleft above
nucleotide in the NBD (Figure S4B), perhaps making it more
accessible to oxidation byMB. Together, these in silico observa-
tions suggest that oxidation of Cys267 and Cys306 in Hsp72
might damage nucleotide binding and inactivate ATP turnover.
Furthermore, these results suggest that sequential oxidation of
C306 and then C267 may reinforce and promote these confor-
mational changes (Figure S4C).
Cys to Asp Mutations ‘‘Phenocopies’’ MB Treatment
In Vitro and in Cells
To test this model, Cys267 and Cys306 of Hsp72 were mutated
to the pseudo-oxidation residue, Asp, and the resulting mutant
proteins were purified. Initial attempts to purify the mutants
on ATP agarose immediately revealed that they had signifi-
cantly reduced affinity for nucleotide (Figure 4D), consistent
with the models. Switching to size exclusion, the mutants
were purified and found to have normal circular dichroism1394 Chemistry & Biology 19, 1391–1399, November 21, 2012 ª2012(CD) spectra (Figure S4A), suggesting that the global structure
was not significantly disrupted by the Asp mutations. However,
partial proteolysis showed that the mutants were more prone to
digestion (Figure S4B), suggesting that they may be more
flexible. It is interesting that MB-treated wild-type Hsp72 is
also prone to proteolysis (Figure S4B), further enforcing the
similarities between the Asp point mutants and the oxidized
wild-type.
Next, the enzymatic activities of the Hsp72 pseudo-oxidation
mutants were examined using ATPase assays, showing that the
C267D and C306D mutants had dramatically decreased enzy-
matic activity (Figure 6A). These mutants essentially behaved
like Hsp72 that had been treated with MB. We next tested the
ability of Hsp72 and the mutants to refold denatured firefly lucif-
erase. These experiments showed that Hsp72 treated with MB
and the C267D, C306D, and C267/306D double mutants all
had reduced refolding activity (Figure S4C). Taken together,
these studies suggest that the Asp mutants phenocopy aspects
of MB-treated Hsp72.
In HeLaC3 cells, overexpression of the C306D mutant
produced modest (40%) reductions in total tau levels and no
significant effect on phosphorylated tau (Figure 5B). Overexpres-
sion of the double mutant (C267/306D) substantially (>70%)
reduced both tau and phosphorylated tau levels (Figure 6B).
These findings provide strong support for MB acting through
oxidation of specific cysteine residues in Hsp72 to reduce
tau levels.Elsevier Ltd All rights reserved
DnaJ (μM)
p 
m
ol
 A
TP
 / 
μg
 H
sp
72
 / 
m
in
DnaJ (μM)
p 
m
ol
 A
TP
 / 
μg
 H
sp
72
 / 
m
in
DnaJ (μM)
p 
m
ol
 A
TP
 / 
μg
 H
sp
72
 / 
m
in
A C267S mutant is partially resistant to MB B C306S mutant is partially resistant to MB
C 
C267, 306S double mutation confers resistence
     to MB
0.0 0.2 0.4 0.6 0.8 1.0
0
5
10
15
20
25
0.0 0.2 0.4 0.6 0.8 1.0
0
5
10
15
20
25
0.0 0.2 0.4 0.6 0.8 1.0
0
5
10
15
20
25
pS396/404 Tau
Total Tau
Flag-Hsp72
GAPDH
MB (µM) -     3    10   50    -     3    10   50    -    3    10    50
Vector Wt Hsp72 C306S Hsp72
D
C306S mutant abolishes the effect of MB
     on tau levels in cells
 Hsp72 WT
Hsp72 C267S
MB+ Hsp72
C267S
 MB + Hsp72 WT
 Hsp72 WT
Hsp72 C306S
MB + Hsp72
C306S
 MB + Hsp72 WT
 Hsp72 WT
Hsp72 C267,306S
MB + Hsp72
C267,306S
 MB + Hsp72 WT
Figure 3. Serine Mutants of Hsp72 Are Resistant to MB Treatment in ATPase and Cell-Based Assays
(A) C267S mutation confers partial resistance to MB (50 mM).
(B) C306S confers partial resistance to MB (50 mM).
(C) C267, 306S double mutation confers resistance to MB (50 mM). All of the ATPase experiments were performed at least twice in triplicate and error bars
are SEM.
(D) Overexpression of the C306S mutation blocks MB-mediated clearance of tau. HeLaC3 cells were transfected with vector, Flag-tagged WT Hsp72, or C306S
Hsp72mutant for 48 hr and then treated with MB for 10min. Samples were analyzed by western blot and the results are representative of experiments performed
in duplicate.
See Figure S3 for the CD spectra of the mutants.
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Hsp72 Is a Redox Sensitive ChaperoneDISCUSSION
One ‘‘arm’’ of the cellular response to redox stress likely involves
the acute protection of proteins from oxidation-induced
unfolding and aggregation (Ilbert et al., 2007). Here, we were
specifically interested in understanding how the Hsp70 family
of chaperones, especially the stress-inducible forms, might be
linked to these types of redox responses. We found that
Hsp72, but not Hsc70, was sensitive to oxidation by either MB
or peroxide. A recent large-scale proteomic study positively
identified Hsp72 as sensitive to oxidation by peroxide in HeLa
cells (Leonard et al., 2009), consistent with this finding. Our
mass spectrometry, modeling, and point mutagenesis results
suggest that oxidation of Hsp72 occurs selectively at two
cysteine residues, Cys267 and Cys306. It is important to note
that Cys306 is uniquely conserved in the stress-inducible
Hsp70 family members and is absent from the constitutive
ones (see Figure S2). Although it might be initially surprising for
such highly homologous proteins to have different biochemical
properties, Goldfarb et al. recently demonstrated that Hsp72
and Hsc70 have opposing effects on the surface expression of
murine epithelial sodium channel (Goldfarb et al., 2006), further
suggesting that even highly conserved Hsp70 isoforms canChemistry & Biology 19, 1391–139sometimes have distinct functions. Together, our findings
suggest that Hsp72, and possibly other stress-inducible Hsp70
family members, are specially adapted for sensing and respond-
ing to redox stress. Based on the observed effects on tau
stability, this redox response may involve switching the triage
decision to favor degradation of misfolded Hsp72 substrates,
perhaps clearing the cytosol of folding intermediates that are
particularly prone to oxidative damage.
What is the molecular mechanism linking oxidation of Hsp72
to a loss of ATPase activity? We propose a model in which
oxidation of the unique and solvent exposed Cys306 leads to
rearrangement of Cys267, such that this residue is now also
sensitive to oxidation (see Figure S4). Thus, although Hsc70
has Cys267, it lacks the critical initiator (i.e., residue Cys306);
therefore, treatment with either MB or peroxide does not inacti-
vate it (see Figure 1). This model further suggests that oxidation
of both Cys267 and Cys306 causes numerous, subtle rearrange-
ments in residues that normally contact nucleotide (Figure 4; Fig-
ure S4). These changes destabilize a number of key contacts,
including hydrogen bonds with ATP, hydrogen bonds with
the phosphate, and a number of hydrophobic interactions
(Table S1). Consistent with this idea, the purified mutants,
C267D and C306D, lacked the ability to bind ATP in vitro9, November 21, 2012 ª2012 Elsevier Ltd All rights reserved 1395
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See Table S1 for details.
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Hsp72 Is a Redox Sensitive Chaperone(Figure 4). Thus, we propose a model in which a cascade of
oxidations severely damages the binding of Hsp72 to nucleotide.
How this rearrangement favors degradation of bound sub-
strates, such as tau, is not yet clear.
Another goal of this work was to better understand the mech-
anism by which MB reduces tau levels in cellular and mouse
models of AD (Jinwal et al., 2009; O’Leary et al., 2010). Although
MB is clearly a promiscuous compound that lacks a classic
‘‘drug-like’’ profile, it is remarkably nontoxic; thus, it is used in
humans for the treatment of a variety of indications, including in-
herited and acute methemoglobinemia, prevention of urinary
tract infections, ifosfamid-induced neurotoxicity, vasoplegic
adrenaline-resistant shock, and pediatric malaria (Schirmer
et al., 2011). Because of MB’s particular promise as an AD ther-
apeutic, we were interested in understanding whether any of its
effects on tau accumulation may be mediated by oxidation of
Hsp72. In this work, we found that mutating Hsp72 Cys267
and/or Cys306 to serine blocked the ability of MB to reduce
tau levels in cells (Figure 3D). This is an important finding
because it strongly links Hsp72 oxidation to effects on tau accu-
mulation. To further enforce this idea, overexpression of the cor-
responding C267/306D pseudo-oxidation double mutant was
a strong ‘‘dominant negative,’’ and it dramatically reduced tau
levels (Figure 5). Together, these results suggest that Hsp721396 Chemistry & Biology 19, 1391–1399, November 21, 2012 ª2012 Elsevier Ltd All rights reoxidation is one important way by which
MB reduces tau accumulation in AD
models. These findings may aid in the
discovery of additional AD therapeutics
that take advantage of this underexplored
mechanism.
Treatments with high levels of MB are
tolerated in cells (Yaglom et al., 2007);
moreover, it is relatively nontoxic in
humans (Schirmer et al., 2011). On firstglance, the global inactivation of Hsp70s might be hypothesized
to be acutely and dramatically toxic, given the proposed roles
of this chaperone family in ‘‘housekeeping’’ activities. However,
another point of view is that the stress-inducible Hsp72 isoform
is specifically concerned with degrading only the substrates
that have been damaged ormisfolded in response to stress (Pratt
and Toft, 2003), protecting the cytosol from the accumulation of
proteotoxic intermediates. In normal cells, the levels of Hsp72
and such misfolded substrates may be low due to the action of
other components of the protein quality controls system. Thus,
MB may have low toxicity because of its unusual selectivity for
the stress-inducible Hsp70 family members. This is an important
finding in the continued search for Hsp70-modifying compounds
with low toxicity and favorable therapeutic benefits. Together,
these findings provide one potential mechanism by which MB
has activity in tau-related diseases, such as AD.
SIGNIFICANCE
The heat shock protein 70 (Hsp70) family of molecular chap-
erones plays a central role in proteostasis, especially in the
response to stress. These proteins have been implicated
in regulating the stability and turnover of a number of
important substrates, including the microtubule-associatedserved
180 °
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(A) Pseudo-oxidation of residue 306 does not
produce global changes in the NBD fold, similar to
what was seen with the C267D mutant (see Fig-
ure 4). C306D is represented in green, and wild-
type (PDB 3JXU) is represented in yellow. The
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synergistic oxidation of C267 and reduced ATP
binding. No specific oxidation state of the thiol is
intended and the results suggest that a series of
oxidations are possible.
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Hsp72 Is a Redox Sensitive Chaperoneprotein tau. Tau aberrantly accumulates in 15 neurodegen-
erative disorders, including Alzheimer’s disease (AD).
Accordingly, there is great interest in finding ways of using
the Hsp70s to restore balance in this system and reduce
tau accumulation. We found that the stress-inducible
Hsp70, Hsp72, is sensitive to oxidation by peroxide or meth-
ylene blue (MB), while the constitutive Hsc70 is resistant.
Mutation of key cysteines in Hsp72 to serine rendered the
chaperone resistant to MB in vitro, and overexpression of
this mutant partially suppressed MB-mediated degradation
of tau in cells. Together, these results suggest that oxidation
of Hsp72 is one mechanism by which MB reduces tau levels.
These results are particularly interesting because this com-
pound has recently undergone clinical evaluation as a tau-
reducing therapy in AD. These results suggest that oxidation
of Hsp72 might be one mechanism to explain the activity of
this clinical candidate.
EXPERIMENTAL PROCEDURES
Proteins and Reagents
Unless otherwise specified, reagents were purchased from Sigma (St. Louis,
MO, USA) or Fisher Scientific (Pittsburgh, PA, USA). Human Hsp72, Hsc70,
and Escherichia coli DnaJ were purified according to published schemes
(Chang et al., 2010). Site-directed mutagenesis primers were designed basedChemistry & Biology 19, 1391–1399, November 21, 2012 ªon previous reports (Zheng et al., 2004), andmuta-
genesis of Hsp72 was carried out in accordance
with the the user manual for the QuickChange
site-directed mutagenesis kit (Stratagene, La
Jolla, CA, USA). The Hsp72 C267S, C306S, and
C267/306S mutants were expressed and purified
using the same protocol as Hsp72 (Chang et al.,
2010). The Hsp72 C267D and C306D mutants
were expressed as previously described (Chang
et al., 2010) and purified using nickel-nitrilotriace-
tic acid His,Bind resin (Novagen, Darmstadt,
Germany), then buffer exchanged into a 25 mM
HEPES buffer (10 mM KCl, 5 mM MgCl2, pH 7.5).
Oxidation of Hsp72/Hsc70
Protein (10 mM) and MB (5 mM) were incubated at
37C for 1 hr. For H2O2 oxidation, protein sample
(10 mM) was incubated with 1 mM H2O2 at 37
C for 1 hr. Treated protein
samples were subsequently dialyzed against buffer A (100 mM Tris-HCl, pH
7.4, 20 mM KCl, 6 mM MgCl2) at 4
C.
ATPase Activity
ATPase activity was measured according to the previously published method
(Chang et al., 2008). Briefly, malachite green-based assays were used to
measure phosphate release from purified Hsp72, Hsc70, or mutants (1 mM).
Reactions were initiated with 1 mM ATP, performed for 60 min, and quenched
before measuring absorbance. Absorbance readings were converted to pico-
moles of ATP using a phosphate standard curve.
Preparation of Dimedone-Modified Hsp70s
MB-treated or untreated Hsp70s (10 mM) were incubated with 5mM dimedone
(5,5-dimethyl-1,3-cyclohexanedione) in buffer A (100 mM Tris-HCl, pH 7.4,
20 mM KCl, 6 mM MgCl2) at room temperature for 1 hr. The samples were
analyzed by SDS-PAGE and stained with colloidal Coomassie blue (Invitrogen,
Carlsbad, CA). Bands corresponding to Hsp72 were excised and stored
at 20C until use.
Mass Spectrometry
In-gel digestion was performed as previously described (Brady et al., 2010).
After reduction (10 mM DTT) and alklylation (65 mM iodoacetamide) of the
free cysteines at room temperature for 30 min, proteins were digested over-
night with trypsin (Promega). Resulting peptides were resolved on a nanocapil-
lary reverse-phase column (Picofritcolumn, New Objective) using a 1% acetic
acid/acetonitrile gradient at 300 nl/min and subjected to LC-MS/MS using2012 Elsevier Ltd All rights reserved 1397
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Figure 6. Pseudo-Oxidation Mutants Phenocopy MB Treatment
(A) The DnaJ-stimulated ATPase activities of purified Hsp72 mutants were reduced, resembling MB-treated wild-type. These experiments were performed at
least three times using two independently prepared samples. Error bars, SEM.
(B) Overexpression of wild-type Hsp72 had little effect on tau levels, but the C306D and C267/306D mutants reduced tau. The gels show two independent
replicates, and the quantification of band intensities includes SEM.
See Figure S4 for the characterization of the mutants.
Chemistry & Biology
Hsp72 Is a Redox Sensitive Chaperonea LTQOrbitrap XLmass spectrometer. MS/MS spectra were searched against
the database considering either carbamidomethyl- or dimedone-modified
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